Shugo Kowata

419 total citations
26 papers, 181 citations indexed

About

Shugo Kowata is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Shugo Kowata has authored 26 papers receiving a total of 181 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 8 papers in Genetics and 6 papers in Oncology. Recurrent topics in Shugo Kowata's work include Platelet Disorders and Treatments (12 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Acute Myeloid Leukemia Research (4 papers). Shugo Kowata is often cited by papers focused on Platelet Disorders and Treatments (12 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Acute Myeloid Leukemia Research (4 papers). Shugo Kowata collaborates with scholars based in Japan, France and United States. Shugo Kowata's co-authors include Yoji Ishida, Shigeki Ito, Kazunori Murai, Tatsuo Oyake, Masatsugu Ema, Ken‐ichi Nomura, Koujiro Tohyama, Sumio Isogai, Yoshiko Fujimoto and Kazumi Sato and has published in prestigious journals such as Blood, Annals of Oncology and British Journal of Haematology.

In The Last Decade

Shugo Kowata

15 papers receiving 176 citations

Peers

Countries citing papers authored by Shugo Kowata

Since Specialization

Citations

This map shows the geographic impact of Shugo Kowata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shugo Kowata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shugo Kowata more than expected).

Fields of papers citing papers by Shugo Kowata

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shugo Kowata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shugo Kowata. The network helps show where Shugo Kowata may publish in the future.

Co-authorship network of co-authors of Shugo Kowata

This figure shows the co-authorship network connecting the top 25 collaborators of Shugo Kowata. A scholar is included among the top collaborators of Shugo Kowata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shugo Kowata. Shugo Kowata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A phase 3 study of the efficacy and safety of avatrombopag in Japanese adults with chronic immune thrombocytopenia 2025 ·International Journal of Hematology ·Hiroki Yamaguchi, Masaki Iino, Shugo Kowata, (unknown), Jun Yamanouchi, Yutaka Imamura, Keita Kirito, Kenji Yokoyama, Tomoki� Ito, (unknown), Motoaki Shiratsuchi, Yoshiaki Tomiyama, (unknown), Jessica Zhang, Brian Jamieson	0
2	Efficacy and Safety of Avatrombopag in Japanese Adults with Chronic Immune Thrombocytopenia: Open-Label, Phase 3 Study 2024 ·Blood ·Hiroki Yamaguchi, Masaki Iino, Yutaka Imamura, Shugo Kowata, (unknown), Jun Yamanouchi, Masato Fujii, Jessica Zhang, Yoshiaki Tomiyama, (unknown)	0
3	P11-4 Efficacy and safety of anti-CD38 antibodies in combination with pomalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma 2023 ·Annals of Oncology ·Tsuyoshi Sato, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Yoshiaki Okano, (unknown), Shugo Kowata, Tatsuo Oyake, Shigeki Ito	0
4	Long-Term Treatment with Fostamatinib in Japanese Patients with Primary Immune Thrombocytopenia: An Open-Label Extension Study Following a Phase 3 Placebo-Controlled, Double-Blind, Parallel-Group Study 2023 ·Blood ·Masataka Kuwana, Tomoki� Ito, Shugo Kowata, Yoshihiro Hatta, Katsumichi Fujimaki, Kensuke Naito, Shingo Kurahashi, (unknown), Kazuki Tanimoto, (unknown), (unknown), Esteban S. Masuda, Yoshiaki Tomiyama	0
5	Association of CD8 + T cells expressing nivolumab-free PD-1 with clinical status in a patient with relapsed refractory classical Hodgkin lymphoma 2023 ·International Journal of Hematology ·Shugo Kowata, (unknown), (unknown), Tsuyoshi Sato, (unknown), (unknown), Akiko Yashima‐Abo, (unknown), Yoshiaki Okano, Tatsuo Oyake, Shigeki Ito	0
6	Fostamatinib for the treatment of Japanese patients with primary immune thrombocytopenia: A phase 3, placebo‐controlled, double‐blind, parallel‐group study 2022 ·British Journal of Haematology ·Masataka Kuwana, Tomoki� Ito, Shugo Kowata, Yoshihiro Hatta, Katsumichi Fujimaki, Kensuke Naito, Shingo Kurahashi, (unknown), Kazuki Tanimoto, (unknown), Yoshiaki Tomiyama, (unknown)	9
7	Fostamatinib for the Treatment of Japanese Patients with Primary Immune Thrombocytopenia: A Phase 3, Placebo-Controlled, Double-Blind, Parallel-Group Study 2022 ·Blood ·Masataka Kuwana, (unknown), Shugo Kowata, Yoshihiro Hatta, Katsumichi Fujimaki, Kensuke Naito, Shingo Kurahashi, (unknown), Kazuki Tanimoto, (unknown), (unknown), Esteban S. Masuda, Yoshiaki Tomiyama	0
8	Autophagosome-rich platelets are increased in immune thrombocytopenia 2020 ·(unknown), Shugo Kowata, (unknown), Kazunori Murai, (unknown), (unknown), (unknown), Jiro Hitomi, Yoji Ishida, Shigeki Ito	0
9	Doripenem versus meropenem as first-line empiric therapy of febrile neutropenia in patients with acute leukemia: a prospective, randomized study 2019 ·Annals of Hematology ·Tatsuo Oyake, (unknown), (unknown), (unknown), (unknown), Ichiro Hanamura, (unknown), (unknown), Shugo Kowata, Shigeki Ito, Yoji Ishida	2
10	Successful cord blood transplantation in an adult acute lymphoblastic leukemia patient with congenital heart disease. 2016 ·PubMed ·Shugo Kowata, (unknown), Yuzo Suzuki, (unknown), Tatsuo Oyake, (unknown), Kotaro Oyama, (unknown), Shigeki Ito, Yoji Ishida	2
11	Comparison of micafungin and voriconazole as empirical antifungal therapies in febrile neutropenic patients with hematological disorders: a randomized controlled trial 2015 ·European Journal Of Haematology ·Tatsuo Oyake, Shugo Kowata, Kazunori Murai, Shigeki Ito, Tomoaki Akagi, Kohmei Kubo, Kenichi Sawada, Yoji Ishida	16
12	Presepsin (soluble CD14 subtype) Is Available in Febrile Neutropenic Patients with Hematological Malignancy As Diagnosis and Assesment Biomarker of Infections 2015 ·Blood ·Tatsuo Oyake, Takayuki Masuda, (unknown), (unknown), Yuzo Suzuki, Yoshiaki Okano, (unknown), (unknown), Shugo Kowata, Shigeki Ito, Yoji Ishida	1
13	Bortezomib induces thrombocytopenia by the inhibition of proplatelet formation of megakaryocytes 2014 ·European Journal Of Haematology ·Kazunori Murai, Shugo Kowata, Tadashi Shimoyama, Akiko Yashima‐Abo, (unknown), Shigeki Ito, Yoji Ishida	21
14	Novel Concept of Platelet Production From Megakaryocyte in Intact Bone Marrow: Proplatelet and Thick Protrusion. 2012 ·Blood ·Shugo Kowata, Sumio Isogai, Kazunori Murai, Shigeki Ito, Koujiro Tohyama, Jiro Hitomi, Yoji Ishida	1
15	Micafungin Versus Voriconazole for Empirical Antifungal Therapy In Febrile Neutropenic Patients with Acute Myeloid Leukemia: A Randomized, Controlled Trial. 2010 ·Blood ·Tatsuo Oyake, Shugo Kowata, Kazunori Murai, Shigeki Ito, Tomoaki Akagi, (unknown), Kenichi Sawada, Yoji Ishida	1
16	Absence of pseudomembranes inClostridium difficile-associated diarrhea in patients using immunosuppression agents 2008 ·Scandinavian Journal of Gastroenterology ·Ken‐ichi Nomura, Yoshiko Fujimoto, (unknown), (unknown), (unknown), Kazumi Sato, Tatsuo Oyake, Shugo Kowata, Hideyuki Konishi, Toshikazu Yoshikawa, Yoji Ishida, Masafumi Taniwaki, (unknown)	53
17	Distinguishing between proliferating nodal lymphoid blasts in chronic myelogenous leukemia and non‐Hodgkin lymphoma: Report of three cases and detection of a bcr/abl fusion signal by single‐cell analysis 2005 ·Pathology International ·Akiko Yashima‐Abo, Takashi Satoh, Toru Abo, (unknown), Shugo Kowata, Shigeki Ito, Yoji Ishida, (unknown), Chihaya Maesawa, Tomoyuki Masuda	7
18	Uncommon karyotypic abnormality, t(11;19)(q23;p13.3), in a patient with blastic phase of chronic myeloid leukemia 2004 ·Cancer Genetics and Cytogenetics ·(unknown), Takeshi Sugawara, Shugo Kowata, (unknown), Shigeki Ito, Kazunori Murai, Yoji Ishida	6
19	Clinical and Biological Significance of CD56 Antigen Expression in Acute Promyelocytic Leukemia 2004 ·Leukemia & lymphoma ·Shigeki Ito, Yoji Ishida, Tatsuo Oyake, (unknown), (unknown), Shugo Kowata, (unknown), (unknown), Takeshi Sugawara, (unknown), (unknown), Kazunori Murai	27
20	Myelodysplastic Syndrome with Bone Marrow Hypoplasia Is Associated with Much Higher Frequency of Apoptosis in CD 34+ Cells. 2004 ·Blood ·Tatsuo Oyake, Shigeki Ito, Shugo Kowata, Kazunori Murai, Yoji Ishida	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact